Healthy Skepticism Library item: 6671

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: report

Consultation workshop: background paper. Direct-to-consumer advertising of prescription drugs
: Drugs Programme 1996 May 28
www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/consult/wkshd2ca.zip

Abstract:

This report provides background information on the subject of direct-to-consumer advertising. It is intended to assist participants in a consultation workshop being sponsored by the Drugs Programme by presenting key facts and issues. It covers briefly, the history of DTCA regulation; provides a context for the workshop; and summarizes the issues. Appendix A covers the current legislative, regulatory and policy framework. Appendix B gives the position of the Drugs Programme on the distinction between advertising and other activities. Appendix C is review of the literature on DTCA drawing mostly on work from the United States. Appendix D is a glossary of terms.

Keywords:
*analysis/*policy statement & guideline/*nonsystematic review/Canada/regulation of promotion/DTCA/direct-to-consumer advertising/doctor-patient relationship/consumer behaviour & knowledge/safety & risk information/broadcast advertisements/print advertisements/consumer drug prices/attitude toward promotion/ATTITUDES REGARDING PROMOTION: CONSUMERS/PATIENTS/ATTITUDES REGARDING PROMOTION: HEALTH PROFESSIONALS/ATTITUDES REGARDING PROMOTION: REGULATORS AND GOVERNMENT/EVALUATION OF PROMOTION: DIRECT-TO-CONSUMER ADVERTISING/INFLUENCE OF PROMOTION: CONSUMER DRUG COSTS/INFLUENCE OF PROMOTION: CONSUMERS AND PATIENTS/INFLUENCE OF PROMOTION: DOCTOR-PATIENT RELATIONSHIP/INFLUENCE OF PROMOTION: PRESCRIBING, DRUG USE/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION